FinTrust Capital Advisors’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $6.28K | Hold |
90
| – | – | ﹤0.01% | 1038 |
|
|
2024
Q2 | $5.83K | Sell |
90
-226
| -72% | -$14.7K | ﹤0.01% | 982 |
|
|
2024
Q1 | $20.5K | Hold |
316
| – | – | ﹤0.01% | 712 |
|
|
2023
Q4 | $20.8K | Hold |
316
| – | – | ﹤0.01% | 672 |
|
|
2023
Q3 | $18K | Hold |
316
| – | – | ﹤0.01% | 669 |
|
|
2023
Q2 | $20.1K | Hold |
316
| – | – | ﹤0.01% | 649 |
|
|
2023
Q1 | $20.1K | Hold |
316
| – | – | ﹤0.01% | 648 |
|
|
2022
Q4 | $20.1K | Hold |
316
| – | – | ﹤0.01% | 647 |
|
|
2022
Q3 | $20K | Hold |
316
| – | – | 0.01% | 718 |
|
|
2022
Q2 | $19K | Hold |
316
| – | – | ﹤0.01% | 746 |
|
|
2022
Q1 | $20K | Hold |
316
| – | – | ﹤0.01% | 762 |
|
|
2021
Q4 | $23K | Hold |
316
| – | – | 0.01% | 710 |
|
|
2021
Q3 | $24K | Hold |
316
| – | – | 0.01% | 685 |
|
|
2021
Q2 | $24K | Hold |
316
| – | – | 0.01% | 704 |
|
|
2021
Q1 | $23K | Hold |
316
| – | – | 0.01% | 670 |
|
|
2020
Q4 | $22K | Hold |
316
| – | – | 0.01% | 654 |
|
|
2020
Q3 | $18 | Hold |
316
| – | – | ﹤0.01% | 669 |
|
|
2020
Q2 | $18K | Hold |
316
| – | – | 0.01% | 636 |
|
|
2020
Q1 | $15K | Hold |
316
| – | – | 0.01% | 684 |
|
|
2019
Q4 | $18K | Hold |
316
| – | – | 0.01% | 655 |
|
|
2019
Q3 | $15K | Hold |
316
| – | – | 0.01% | 675 |
|
|
2019
Q2 | $17K | Hold |
316
| – | – | 0.01% | 635 |
|
|
2019
Q1 | $17K | Hold |
316
| – | – | 0.01% | 643 |
|
|
2018
Q4 | $15K | Buy |
+316
| New | +$15K | 0.01% | 664 |
|